DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 198 filers reported holding DEPOMED INC in Q1 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $981,000 | -33.3% | 169,400 | +23.7% | 0.00% | – |
| Q2 2017 | $1,470,000 | -88.5% | 136,905 | -80.7% | 0.00% | -100.0% |
| Q4 2016 | $12,808,000 | -14.0% | 710,757 | +19.3% | 0.00% | 0.0% |
| Q3 2016 | $14,885,000 | +27.7% | 595,656 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $11,656,000 | -37.9% | 594,103 | -55.9% | 0.00% | -33.3% |
| Q1 2016 | $18,783,000 | +4.8% | 1,348,366 | +36.4% | 0.00% | +50.0% |
| Q4 2015 | $17,927,000 | +325.9% | 988,821 | +342.8% | 0.00% | +100.0% |
| Q3 2015 | $4,209,000 | -64.2% | 223,291 | -71.1% | 0.00% | -50.0% |
| Q3 2014 | $11,753,000 | +42.3% | 773,764 | +30.2% | 0.00% | +100.0% |
| Q2 2014 | $8,262,000 | -45.3% | 594,419 | -43.0% | 0.00% | -50.0% |
| Q1 2014 | $15,110,000 | +185.5% | 1,042,100 | +108.3% | 0.00% | +100.0% |
| Q4 2013 | $5,293,000 | +265.0% | 500,300 | +158.2% | 0.00% | – |
| Q3 2013 | $1,450,000 | +31.8% | 193,800 | -1.2% | 0.00% | – |
| Q2 2013 | $1,100,000 | – | 196,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
| Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
| Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
| PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
| HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
| ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
| Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
| Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
| TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |